VERO Venus Concept

Venus Concept Celebrates Successful Completion of its NEXThetics Events Across North America

Venus Concept Celebrates Successful Completion of its NEXThetics Events Across North America

TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic technology leader, announces the successful completion of its NEXThetics events held across several major cities in North America. NEXThetics events bring together Venus Concept’s network of aesthetic leaders and practitioners and have seen a significant increase in popularity and attendance. Since our pilot events, the Company has hosted thousands of registrants, including its largest gathering to date in Houston, Texas on June 22, 2024.

“NEXThetics Houston was an outstanding event, centering on the core principles of the latest technology, networking, and delivering an unparalleled experience among attendees,” says Dr. Cheryl Haseeb of Pura Medical Aesthetics in Houston, Texas. “The attendees were highly engaged and eager to learn about the science behind this cutting-edge brand. They left energized and inspired to take their practice to the next level. It's truly inspiring to witness the positive impact this event has had on our professional community.”

NEXThetics events are designed to showcase Venus Aesthetic Intelligence’s (“Venus AI”) Total Practice Performance philosophy and innovative technologies, including the recent successful launch of the Venus Versa Pro and strategies for maximizing profitability with Venus AI technologies. A broad spectrum of medical aesthetic professionals including dermatologists, plastic surgeons, hair restoration experts, practitioners, and spa owners have attended each event.

Venus AI’s direction focuses on integrating Aesthetic Intelligence into every aspect of its offerings, with the goal of enhancing total practice performance for all its partners. This holistic approach ensures that clients not only receive top-of-the-line technology but also the necessary support to achieve sustained success and profitability with dedicated teams and resources allocated to all Venus AI partners. These events also enhance brand recognition and provide attendees with opportunities to engage and learn from industry luminaries which provides a variety of perspectives, to help each participant understand what the latest trends are to better their practices or offerings and Venus Concept’s strength and ability to help in that journey.

Looking ahead to the remainder of 2024, NEXThetics Events will continue to expand across the United States, with upcoming events in Phoenix, Las Vegas, New York City, Atlanta, Dallas and Minneapolis.

"We are excited to continue driving innovation and education within the aesthetics and hair restoration industry," says Ross Portaro, Executive Vice President & General Manager, Global Sales & Marketing of Venus Concept. "Join us at the future NEXThetics Events to elevate your practice and stay ahead of the curve."

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 12 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa PRO, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, and Masters Special Situations.



Investor Relations Contact:
ICR Westwicke on behalf of Venus Concept:
Mike Piccinino, CFA
 
EN
27/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Venus Concept

 PRESS RELEASE

Venus Concept Announces Intention to Voluntary Delist from Nasdaq and ...

Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC TORONTO, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) announced today its voluntarily decision to delist its common stock from the NASDAQ Capital Market (“Nasdaq”) and deregister its common stock with the Securities and Exchange Commission (the “SEC”). The Company is in compliance with applicable Nasdaq listing requirements, but the Company’s Board of Directors has concluded the resources required to continue its reporting obligations with the SEC are great...

 PRESS RELEASE

Venus Concept Announces Third Quarter 2025 Financial Results

Venus Concept Announces Third Quarter 2025 Financial Results TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2025. Summary of Financial Results & Recent Progress: Energy Based Device (“EBD”) revenues showing signs of stabilization. Total EBD systems sales of $9.6 million, up 2% year over year Total revenue for the third quarter of $13.8 million, down 8% year-over-year and down 12% qua...

 PRESS RELEASE

Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Mu...

Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin Treatments Venus NOVA is the first product clearance from the Company’s new R&D strategy TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global leader in medical aesthetic technology, announced today that it has received a 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market the Venus NOVA™, the Company’s next-generation multi-application platform designed to redefine non-invasive treatm...

 PRESS RELEASE

Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transac...

Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction Reduction of outstanding debt by Madryn Asset Management continues to improve the Company’s financial position TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on September 30, 2025, the Company exchanged the full $11.48 million balance of its subordinated convertible notes held by affiliates of Madryn Asset Management, LP (“Madryn”) for 545,335 shares of its Series Y preferred stock...

 PRESS RELEASE

Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial R...

Venus Concept to Release Third Quarter of Fiscal Year 2025 Financial Results on November 13, 2025 TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2025 financial results will be released before the market opens on Thursday, November 13, 2025. Management will host a conference call at 8:00 a.m. Eastern Time on November 13, 2025 to discuss the results of the quarter and host a question and answer session. Those who would like to par...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch